Nagasawa T

No ORCID on file · 4 papers in corpus
observational 2026
Cancer Immunology, Immunotherapy ·doi:10.1007/s00262-026-04324-z

Transcriptomic classification methods have been proposed for ovarian clear cell carcinoma. However, their clinical significance and association with pathologically evaluated tumor-infiltrating lymphocytes (TILs) remain unclear. We establish…

lab-animal 2023
Clinical and experimental pharmacology & physiology ·doi:10.1111/1440-1681.13817

The hypothalamic-pituitary-gonadal (HPG) axis is an important regulatory mechanism involved primarily in the development and regulation of the reproductive systems. The suppression of the HPG axis by gonadotropin-releasing hormone (GnRH) an…

review 2021
Cancers ·doi:10.3390/cancers13236120

Ovarian cancer has the worst prognosis among gynecological cancers. In particular, clear cell and mucinous carcinomas are less sensitive to chemotherapy. The establishment of new therapies is necessary to improve the treatment outcomes for …

observational 2007
British journal of cancer ·doi:10.1038/sj.bjc.6603552

Ovarian cancer, and clear cell carcinoma in particular, reportedly increases the risk of venous thromboembolism (VTE). However, the mechanisms remain unclear. Tissue factor (TF) supposedly represents a major factor in the procoagulant activ…